MYND Life Sciences Inc. (MYND.CN) Research

Headquartered in Kelowna, Canada, MYND Life Sciences Inc. operates as a neuro-pharmaceutical enterprise focused on creating innovative therapies for depressive disorders. The company conducts scientific research and clinical trials across Canada and the United States to develop drugs derived from neuro-anti-inflammatory compounds. A significant part of their work involves the study and development of psilocin and psilocybin extracts, as well as their synthetic analogs.

Market snapshot

Symbol
MYND.CN
Price
$0.07
Day change
0.00%
Market cap
$3.3M
P/E ratio
-2.18x
52-week range
0.01-0.14
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • AREV Life Sciences Global Corp. (AREV.CN)
  • Awakn Life Sciences Corp. (AWKN.NE)
  • Body and Mind Inc. (BAMM.CN)
  • Filament Health Corp. (FH.NE)
  • GABY Inc. (GABY.CN)
  • Intellipharmaceutics International Inc. (IPCI.TO)
  • ManifestSeven Holdings Corporation (MSVN.CN)
  • North Bud Farms Inc. (NBUD.CN)

Open MYND Life Sciences Inc. (MYND.CN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.